International Journal of High Risk Behaviors and Addiction

Published by: Kowsar
Uncorrected Proof scheduled for 7 (4)

Inpatient Buprenorphine-Assisted Withdrawal for Treatment of Vulnerable Adolescents with Opioids Use Disorder in Zahedan, Iran: An Observational Study

Mahboubeh Firouzkouhi Moghadam 1 , 2 , Seyed Sepehr Hashemian 3 , Ahmad Hajebi 4 , Masoud Pishjoo 5 and Alireza Noroozi 6 , 7 , *
Authors Information
1 Child and Adolescent Psychiatry Department, Zahedan University of Medical Sciences, Zahedan, Iran
2 Research Center for Children and Adolescents Health, Zahedan University of Medical Sciences, Zahedan, Iran
3 Department of Psychology and Educational Sciences, Allameh Tabataba'i University, Tehran, Iran
4 Psychiatric Department, Research Center for Addiction and Risky Behavior (ReCARB), Iran University of Medical Sciences (IUMS), Tehran, Iran
5 Mashhad University of Medical Sciences, Mashhad, Iran
6 Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran
7 Department of Neuroscience and Addiction Studeis, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • International Journal of High Risk Behaviors and Addiction: In Press (In Press); e66470
  • Published Online: December 3, 2018
  • Article Type: Research Article
  • Received: January 19, 2018
  • Revised: September 10, 2018
  • Accepted: October 25, 2018
  • DOI: 10.5812/ijhrba.66470

To Cite: Firouzkouhi Moghadam M, Hashemian S S, Hajebi A, Pishjoo M, Noroozi A. Inpatient Buprenorphine-Assisted Withdrawal for Treatment of Vulnerable Adolescents with Opioids Use Disorder in Zahedan, Iran: An Observational Study, Int J High Risk Behav Addict. Online ahead of Print ; In Press(In Press):e66470. doi: 10.5812/ijhrba.66470.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Amin-Esmaeili M, Rahimi-Movaghar A, Sharifi V, Hajebi A, Radgoodarzi R, Mojtabai R, et al. Epidemiology of illicit drug use disorders in Iran: Prevalence, correlates, comorbidity and service utilization results from the Iranian mental health survey. Addiction. 2016;111(10):1836-47. doi: 10.1111/add.13453. [PubMed: 27177849].
  • 2. Iran Drug Control Headquarter. Main results of national epidemiologic study of drug use in Iran, 2011 (bureau of planning and information technologies). Tehran: Drug Control Headquarter Publications; 2015.
  • 3. Akhgari M, Jokar F, Bahmanabadi L, Etemadi Aleagha A. Street-level heroin seizures in Iran: A survey of components. J Subst Use. 2012;17(4):348-55. doi: 10.3109/14659891.2011.592898.
  • 4. Mohammadkhani S. [Prevalence of cigarette, alcohol and psychoactive substances use among Iranian adolescents]. J Kerman Uni. 2011;19(1):32-48. Persian.
  • 5. Ahmad Khaniha AR, Torknejad S, Hosseini-Moghadam MH. [Epidemiology of depression and sexual abuse among street children]. Andisheh va Raftar. 2002;8(1):14-20. Persian.
  • 6. Ahmad Khaniha AR, Hakim Shooshtari M, Mohammadian M, Bidaki R, Pourrashidi Boshrabadi A. Familial characteristics of street children in Tehran, Iran. Iran J Psychiatry Behav Sci. 2014;8(2):86-9. [PubMed: 25053962]. [PubMed Central: PMC4105609].
  • 7. Ataei B, Nokhodian Z, Babak A, Shaaei P, Mohammadzadeh M, Sadeghi M. [Prevalence of hepatitis C and HIV among street children and adolescents in Isfahan]. J Med School. 2009;67(11):811-6. Persian.
  • 8. Vameghi M, Sajjadi H, Rafiei H, Rashidian A. [Systematic review of street children studies during last decade (poverty, risk factor for turning to street children)]. Soc Welfare Q. 1388;9(35):337-78. Persian.
  • 9. Vameghi M, Dejman M, Rafiei H, Forouzan A, Roshanfekr P. [Rapid situational assessment of street children in Tehran]. Soc Stud Res Iran. 1394;4(1):33-57. Persian.
  • 10. Iran Cabinet. Regulation for regularization of street children. Ministry of Welfare and Social Security; 2005.
  • 11. Deas D, Thomas SE. An overview of controlled studies of adolescent substance abuse treatment. Am J Addict. 2001;10(2):178-89. [PubMed: 11444159].
  • 12. Galanter M, Glickman L, Singer D. An overview of outpatient treatment of adolescent substance abuse. Subst Abus. 2007;28(2):51-8. doi: 10.1300/J465v28n02_07. [PubMed: 19266713].
  • 13. Kaminer Y, Marsch LA. Pharmacotherapy of adolescent substance use disorders. In: Kaminer Y, Winters KC, editors. Clinical manual of adolescent substance abuse treatment. Arlington, VA, USA: American Psychiatric Publishing; 2011.
  • 14. Marsch LA, Bickel WK, Badger GJ, Stothart ME, Quesnel KJ, Stanger C, et al. Comparison of pharmacological treatments for opioid-dependent adolescents: A randomized controlled trial. Arch Gen Psychiatry. 2005;62(10):1157-64. doi: 10.1001/archpsyc.62.10.1157. [PubMed: 16203961].
  • 15. Marsch LA, Moore SK, Borodovsky JT, Solhkhah R, Badger GJ, Semino S, et al. A randomized controlled trial of buprenorphine taper duration among opioid-dependent adolescents and young adults. Addiction. 2016;111(8):1406-15. doi: 10.1111/add.13363. [PubMed: 26918564]. [PubMed Central: PMC4940230].
  • 16. Woody GE, Poole SA, Subramaniam G, Dugosh K, Bogenschutz M, Abbott P, et al. Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: A randomized trial. JAMA. 2008;300(17):2003-11. doi: 10.1001/jama.2008.574. [PubMed: 18984887]. [PubMed Central: PMC2610690].
  • 17. Lehmann WX. The use of 1-alpha-acetyl-methadol (LAAM) as compared to methadone in the maintenance and detoxification of young heroin addicts. 1973 [proceedings]. NIDA Res Monogr. 1976;(8):82-3. [PubMed: 792705].
  • 18. Bell J, Mutch C. Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: A file review. Drug Alcohol Rev. 2006;25(2):167-71. doi: 10.1080/09595230500537670. [PubMed: 16627307].
  • 19. Smyth BP, Fagan J, Kernan K. Outcome of heroin-dependent adolescents presenting for opiate substitution treatment. J Subst Abuse Treat. 2012;42(1):35-44. doi: 10.1016/j.jsat.2011.07.007. [PubMed: 21940134].
  • 20. Nielsen S, Larance B, Degenhardt L, Gowing L, Kehler C, Lintzeris N. Opioid agonist treatment for pharmaceutical opioid dependent people. Cochrane Database Syst Rev. 2016;(5). CD011117. doi: 10.1002/14651858.CD011117.pub2. [PubMed: 27157143].
  • 21. Momtazi S, Noroozi A, Rawson R. An overview of iran drug treatment and harm reduction programs. In: el-Guebaly N, Carrà G, Galanter M, editors. Textbook of addiction treatment international perspectives. Springer; 2015. p. 543-54.
  • 22. Walsh SL, Eissenberg T. The clinical pharmacology of buprenorphine: Extrapolating from the laboratory to the clinic. Drug Alcohol Depend. 2003;70(2 Suppl):S13-27. [PubMed: 12738347].
  • 23. Firouzkouhi Moghadam M, Hashemian SS, Pishjoo M, Ghasemi S, Hajebi A, Noroozi A. Inpatient opioid withdrawal management of street children and adolescents admitted to child and adolescent psychiatric ward: A preliminary case series. Iran J Pediatr. 2016;26(4). e5133. doi: 10.5812/ijp.5133. [PubMed: 27729958]. [PubMed Central: PMC5046230].
  • 24. Center for Substance Abuse Treatment. Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2004.
  • 25. Tanner-Smith EE, Wilson SJ, Lipsey MW. The comparative effectiveness of outpatient treatment for adolescent substance abuse: A meta-analysis. J Subst Abuse Treat. 2013;44(2):145-58. doi: 10.1016/j.jsat.2012.05.006. [PubMed: 22763198]. [PubMed Central: PMC3477300].
  • 26. Mee-Lee D. The ASAM criteria: treatment criteria for addictive, substance-related, and co-occurring conditions. 3rd ed. American Society of Addiction Medicine; 2013.
  • 27. Embleton L, Atwoli L, Ayuku D, Braitstein P. The journey of addiction: Barriers to and facilitators of drug use cessation among street children and youths in Western Kenya. PLoS One. 2013;8(1). e53435. doi: 10.1371/journal.pone.0053435. [PubMed: 23326428]. [PubMed Central: PMC3541137].
  • 28. Hogue A, Henderson CE, Schmidt AT. Multidimensional predictors of treatment outcome in usual care for adolescent conduct problems and substance use. Adm Policy Ment Health. 2017;44(3):380-94. doi: 10.1007/s10488-016-0724-7. [PubMed: 26884380]. [PubMed Central: PMC4987263].
  • 29. Connolly JA, Joly LE. Outreach with street-involved youth: A quantitative and qualitative review of the literature. Clin Psychol Rev. 2012;32(6):524-34. doi: 10.1016/j.cpr.2012.05.006. [PubMed: 22728669].
  • 30. Chakrabarti A, Woody GE, Griffin ML, Subramaniam G, Weiss RD. Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: Secondary analyses from a NIDA clinical trials network study. Drug Alcohol Depend. 2010;107(2-3):253-6. doi: 10.1016/j.drugalcdep.2009.10.014. [PubMed: 19948382]. [PubMed Central: PMC2821971].
  • 31. Embleton L, Mwangi A, Vreeman R, Ayuku D, Braitstein P. The epidemiology of substance use among street children in resource-constrained settings: A systematic review and meta-analysis. Addiction. 2013;108(10):1722-33. doi: 10.1111/add.12252. [PubMed: 23844822]. [PubMed Central: PMC3776018].
  • 32. Nikfarjam A, Shokoohi M, Shahesmaeili A, Haghdoost AA, Baneshi MR, Haji-Maghsoudi S, et al. National population size estimation of illicit drug users through the network scale-up method in 2013 in Iran. Int J Drug Policy. 2016;31:147-52. doi: 10.1016/j.drugpo.2016.01.013. [PubMed: 26980349].
  • 33. Hops H, Ozechowski TJ, Waldron HB, Davis B, Turner CW, Brody JL, et al. Adolescent health-risk sexual behaviors: Effects of a drug abuse intervention. AIDS Behav. 2011;15(8):1664-76. doi: 10.1007/s10461-011-0019-7. [PubMed: 21833690]. [PubMed Central: PMC3215274].
  • 34. Kirby D. Antecedents of adolescent initiation of sex, contraceptive use, and pregnancy. Am J Health Behav. 2002;26(6):473-85. [PubMed: 12437022].
  • 35. Subramaniam GA, Warden D, Minhajuddin A, Fishman MJ, Stitzer ML, Adinoff B, et al. Predictors of abstinence: National Institute of Drug Abuse multisite buprenorphine/naloxone treatment trial in opioid-dependent youth. J Am Acad Child Adolesc Psychiatry. 2011;50(11):1120-8. doi: 10.1016/j.jaac.2011.07.010. [PubMed: 22024000]. [PubMed Central: PMC3786351].
  • 36. Matson SC, Hobson G, Abdel-Rasoul M, Bonny AE. A retrospective study of retention of opioid-dependent adolescents and young adults in an outpatient buprenorphine/naloxone clinic. J Addict Med. 2014;8(3):176-82. doi: 10.1097/ADM.0000000000000035. [PubMed: 24695018].
  • 37. Vourakis C. Admission variables as predictors of completion in an adolescent residential drug treatment program. J Child Adolesc Psychiatr Nurs. 2005;18(4):161-70. doi: 10.1111/j.1744-6171.2005.00031.x. [PubMed: 16236098].
  • 38. Strang J, McCambridge J, Best D, Beswick T, Bearn J, Rees S, et al. Loss of tolerance and overdose mortality after inpatient opiate detoxification: Follow up study. BMJ. 2003;326(7396):959-60. doi: 10.1136/bmj.326.7396.959. [PubMed: 12727768]. [PubMed Central: PMC153851].
  • 39. Bird SM, Hutchinson SJ. Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996-99. Addiction. 2003;98(2):185-90. [PubMed: 12534423].
  • 40. Leach D, Oliver P. Drug-related death following release from prison: A brief review of the literature with recommendations for practice. Curr Drug Abuse Rev. 2011;4(4):292-7. [PubMed: 21834754].
  • 41. Pecoraro A, Fishman M, Ma M, Piralishvili G, Woody GE. Pharmacologically assisted treatment of opioid-dependent youth. Paediatr Drugs. 2013;15(6):449-58. doi: 10.1007/s40272-013-0041-5. [PubMed: 23912754].
  • 42. Hulse GK, Tait RJ. A pilot study to assess the impact of naltrexone implant on accidental opiate overdose in ‘high-risk’ adolescent heroin users. Addict Biol. 2003;8(3):337-42. doi: 10.1080/13556210310001602257. [PubMed: 13129836].
  • 43. Fishman MJ, Winstanley EL, Curran E, Garrett S, Subramaniam G. Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: Preliminary case-series and feasibility. Addiction. 2010;105(9):1669-76. doi: 10.1111/j.1360-0443.2010.03015.x. [PubMed: 20626723].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments